LY3537982,Abemaciclib,Pembrolizumab,LY3295668,Cetuximab,Pemetrexed,Cisplatin,Carboplatin
Eli Lilly,Merck
['lillypad']
 presented new data on kras g12 inhibitor at , hoping to have a first-line treatment in the works.
#elilillyandcompany #aacr2023 #aacr #cancerresearch #biospace 
Your source for biopharma news and jobs